866-997-4948(US-Canada Toll Free)

ImmusanT, Inc. - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 19 Pages


ImmusanT, Inc. (ImmusanT) is a biotechnology company. It focuses on the development of treatment, and diagnostic and monitoring tools for managing patients suffering from celiac disease. Celiac disease is a condition that causes the damage of small intestine lining and prevents it from absorbing parts of food that are necessary for staying healthy. The company is currently developing peptide-based therapeutic vaccine, Nexvax2, for treating, preventing, and diagnosing celiac disease.

It is developing a technology emerged from the research performed at The Walter and Eliza Hall Institute of Medical Research (WEHI), Australia, and at the University of Oxford, the UK. ImmusanT is headquartered in Cambridge, Massachusetts, the US.

This report is a source for data, analysis and actionable intelligence on the ImmusanT, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3

Key Facts 4
ImmusanT, Inc. - Major Products and Services 5
ImmusanT, Inc. Pipeline Products by Equipment Type 6
ImmusanT, Inc. Pipeline Products by Development Stage 8
ImmusanT, Inc. Pipeline Products by Therapy Area 10
ImmusanT Diagnostic Test - Irritable Bowel Syndrome 12
ImmusanT Diagnostic Test - Irritable Bowel Syndrome Product Status 12
ImmusanT Diagnostic Test - Irritable Bowel Syndrome Product Description 12
Nexvax2 Blood-Based Diagnostic Test 13
Nexvax2 Blood-Based Diagnostic Test Product Status 13
Nexvax2 Blood-Based Diagnostic Test Product Description 13
Serology Test - Celiac Disease 14
Serology Test - Celiac Disease Product Status 14
Serology Test - Celiac Disease Product Description 14
ImmusanT, Inc. - Key Competitors 15
ImmusanT, Inc. - Key Employees 16
ImmusanT, Inc. - Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
ImmusanT, Inc., Recent Developments 18
Aug 16, 2012: ImmusanT Relocates Offices To New Facility 18
Mar 19, 2012: ImmusanT Names Patrick Griffin As Chief Medical Officer 18

Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Table


ImmusanT, Inc., Key Facts 1
ImmusanT, Inc. Key Pipeline Products by Equipment Type 1
ImmusanT, Inc. Key Pipeline Products by Therapy Area 1
ImmusanT, Inc. Key Pipeline Products by Development Stage 1
ImmusanT, Inc., Key Facts 4
ImmusanT, Inc., Major Products and Services 5
ImmusanT, Inc. Number of Pipeline Products by Equipment Type 6
ImmusanT, Inc. Pipeline Products by Equipment Type 7
ImmusanT, Inc. Number of Pipeline Products by Development Stage 8
ImmusanT, Inc. Pipeline Products by Development Stage 9
ImmusanT, Inc. Number of Pipeline Products by Therapy Area 10
ImmusanT, Inc. Pipeline Products by Therapy Area 11
ImmusanT Diagnostic Test - Irritable Bowel Syndrome - Product Status 12
ImmusanT Diagnostic Test - Irritable Bowel Syndrome - Product Description 12
Nexvax2 Blood-Based Diagnostic Test - Product Status 13
Nexvax2 Blood-Based Diagnostic Test - Product Description 13
Serology Test - Celiac Disease - Product Status 14
Serology Test - Celiac Disease - Product Description 14
ImmusanT, Inc., Key Employees 16

List of Chart


ImmusanT, Inc. Pipeline Products by Equipment Type 6
ImmusanT, Inc. Pipeline Products by Development Stage 8
ImmusanT, Inc. Pipeline Products by Therapy Area 10

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *